Arix Bioscience plc is 10% Owner at Harpoon Therapeutics, Inc. (HARP). They have made 5 open-market trades across 3 companies since 2018, most recently 2020-05-28.
CIK 0001700449
3 open-market purchases totalling $16.0M since 2018, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HARP | SELL | 2020-05-27 | 2020-05-29 | $21.36 | $16.2M | -15.0% | -23.7% | -40.7% |
| IMRA | BUY | 2020-03-16 | 2020-03-16 | $16.00 | $3.0M | +3.0% | +0.4% | +150.4% |
| HARP | SELL | 2019-12-06 | 2019-12-10 | $17.75 | $10.1M | +4.4% | -15.1% | -14.5% |
| HARP | BUY | 2019-02-12 | 2019-02-14 | $14.00 | $6.0M | +5.1% | -14.7% | -29.0% |
| LOGC | BUY | 2018-10-23 | 2018-10-26 | $10.00 | $7.0M | -13.8% | -11.9% | -11.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.